Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Lucian Radu Chirieac, M.D.

Co-Author

This page shows the publications co-authored by Lucian Chirieac and Yin Hung.
Connection Strength

6.305
  1. Pathology of Malignant Pleural Mesothelioma. Thorac Surg Clin. 2020 Nov; 30(4):367-382.
    View in: PubMed
    Score: 0.927
  2. How should molecular findings be integrated in the classification for lung cancer? Transl Lung Cancer Res. 2020 Oct; 9(5):2245-2254.
    View in: PubMed
    Score: 0.921
  3. Molecular characterization of diffuse malignant peritoneal mesothelioma. Mod Pathol. 2020 11; 33(11):2269-2279.
    View in: PubMed
    Score: 0.901
  4. Molecular characterization of localized pleural mesothelioma. Mod Pathol. 2020 02; 33(2):271-280.
    View in: PubMed
    Score: 0.850
  5. When You Hear Hoofbeats, Look for Horses, Not Zebras-Reply. JAMA Oncol. 2018 07 01; 4(7):1011-1012.
    View in: PubMed
    Score: 0.788
  6. Novel insights and recent discoveries on the genetics and pathogenesis of malignant mesothelioma. J Thorac Dis. 2018 Mar; 10(3):1314-1317.
    View in: PubMed
    Score: 0.770
  7. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma. JAMA Oncol. 2018 Feb 01; 4(2):235-238.
    View in: PubMed
    Score: 0.766
  8. Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma. Cancer. 2019 Dec 01; 125(23):4164-4171.
    View in: PubMed
    Score: 0.213
  9. Large-scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma. J Pathol. 2021 01; 253(1):68-79.
    View in: PubMed
    Score: 0.058
  10. Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases. Mod Pathol. 2021 02; 34(2):380-395.
    View in: PubMed
    Score: 0.058
  11. Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel. Mod Pathol. 2020 02; 33(2):281-296.
    View in: PubMed
    Score: 0.053
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.